Dr Maycock observed that the prevalence of hepatitis in the UK associated with UK blood and blood products had "long been smaller" than that in the US, but added "Until concentrate prepared from UK plasma is available, I would have said the benefits attaching to Hemofil and other similar concentrates of antihaemophilic factor, used with discrimination, outweigh the risk".